Pharsight

Advil Allergy Sinus patents expiration

ADVIL ALLERGY SINUS's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7863287 HALEON US HOLDINGS Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines
Feb, 2027

(2 years from now)

Advil Allergy Sinus is owned by Haleon Us Holdings.

Advil Allergy Sinus contains Chlorpheniramine Maleate; Ibuprofen; Pseudoephedrine Hydrochloride.

Advil Allergy Sinus has a total of 1 drug patent out of which 0 drug patents have expired.

Advil Allergy Sinus was authorised for market use on 19 December, 2002.

Advil Allergy Sinus is available in tablet;oral dosage forms.

The generics of Advil Allergy Sinus are possible to be released after 28 February, 2027.

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

Drugs and Companies using CHLORPHENIRAMINE MALEATE; IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE ingredient

Market Authorisation Date: 19 December, 2002

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage

ADVIL ALLERGY SINUS family patents

Family Patents